Dr R. Katie Morris MBChB, PhD, MRCOG

Dr R. Katie Morris

Institute of Metabolism and Systems Research
Senior Clinical Lecturer in Maternal Fetal Medicine

Contact details

Academic Department of Obstetrics & Gynaecology
Academic Floor, Third Floor
Birmingham Women's Foundation Trust
B15 2TG

Katie’s research aims to improve the care for women with multiple pregnancies or fetal anomalies and growth restriction, employing prognostic and diagnostic research, modelling, systematic reviews and trials.


  • PhD Obstetrics and Gynaecology 2011.
  • MRCOG 2003
  • MBChB Hons 1998


Dr Morris was appointed as an Honorary Consultant and Senior Lecturer in Maternal and Fetal Medicine at the University of Birmingham (and Birmingham Women’s NHS Foundation Trust) in January 2015.

She qualified from University of Liverpool in 1998 and then performed house jobs and specialist training within the East Midlands Deanery. In 2005 she came to Birmingham to commence her research and in 2008 commenced an MRC Clinical Research Training Fellowship. This led to the award of her PhD from the University of Birmingham in 2011.

Following her period in research, Dr Morris returned to clinical training as an NIHR Clinical Lecturer in Maternal Fetal medicine at the University of Birmingham/Birmingham Women’s Hospital NHS Foundation Trust. In 2014 she obtained her CCT in Obstetrics and Gynaecology and subspecialty accreditation in Maternal and Fetal Medicine from the Royal College of Obstetricians and Gynaecologists.

 Her current role is as a member of a team of seven accredited consultant subspecialists providing regional and supra-regional care for pregnant women with fetal medicine problems at the West Midlands Fetal Medicine Centre which is situated within the Birmingham Women’s NHS Foundation Trust. Her clinical expertise relates to prenatal diagnosis, the diagnosis of fetal anomalies, conditions requiring fetal therapy including complications of monochorionic twins and intrauterine growth restriction and high risk obstetrics including maternal cardiac disease. Her research relates to her areas of clinical expertise and employs diverse methodologies including prognostic modelling, test accuracy research, epidemiology studies, randomised controlled trials, systematic reviews and meta-analyses. This research is funded from research councils and charities including MRC, HTA, Wellbeing of Women, British Maternal and Fetal Medicine Society, Twins and Multiple Births Association, Mary Crosse Foundation and Richard and Jack Wiseman Trust.


Dr Morris provides undergraduate teaching for the following modules and is a personal mentor for the MBChB programme:

  • Second year MBChB Reproduction, Genes and Development Module
  • Second year MBChB – Fetal Medicine Personal Interest Project
  • Fifth year MBChB:

-        Obstetrics and Gynaecology academic in days and ward based teaching on attachment

-        Clinical Communication across the patient journey module

Dr Morris also provides postgraduate teaching for Obstetrics and Gynaecology and Maternal Fetal medicine. She is also a Senior Clinical examiner for the fifth year MBChB programme.

Postgraduate supervision

Dr Morris provides supervision to PhD and Mres students.


Dr Morris’s research interests are fetal growth restriction, prognostic and diagnostic research in Obstetrics, complications of multiple pregnancy, invasive therapies in fetal medicine and the role of folic acid supplementation in pregnancy. Her research involves systematic reviews and meta-analysis, prognostic modelling, randomised controlled trials of therapies and cohort and epidemiology studies. Current research grants are “OMMIT study – prediction of adverse outcome in monochorionic twins.”; “QUIDS – Quantitative Fibronectin to help Decision-making in women with Symptoms of Preterm Labour” and “Epigenetic and metabolomics in small for gestational fetuses related to folic acid supplementation.”

Other activities

Dr Morris has served as a committee member of the British Maternal Fetal Medicine Society, is a peer reviewer for international journals and major grant funding bodies including the MRC and HTA. She is an author of national guidelines in Obstetrics and a member of the STARD group (Standards for Reporting of Diagnostic Accuracy).



Selected recent publications:

Dr Morris has over 50 publications with an h-index of 11 and RG score of 34.

Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA et STARD group. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Radiology 2015;277(3):826-32, doi.10.1148/radiol.2015151516

When is birthweight at term (≥37 weeks' gestation) abnormally low? A systematic review and meta-analysis of the prognostic and predictive ability of current birthweight standards for childhood and adult outcomes. Malin GL, Morris RK, Riley RD, Teune MJ, Khan KS. BJOG. 2015 Apr;122(5):634-42

Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. Hodgetts VA, Morris RK, Francis A, Gardosi J, Ismail KM. BJOG. 2015 Mar;122(4):478-90

Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, Daniels JP, Khan KS, Deeks J, Kilby MD; Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) Collaborative Group. Lancet. 2013 Nov 2;382(9903):1496-506.

Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. BMJ. 2012 Jul 9;345:e4342.

Co-twin prognosis after single fetal death: a systematic review and meta-analysis. Hillman SC, Morris RK, Kilby MD. Obstet Gynecol. 2011 Oct;118(4):928-40.